ANKEBIO ANTI-PD1 PRODUCT

【INN】Recombinant anti-PD1 Humanized Monoclonal Antibody Injection

【Indication】Advanced cancers

【Protein Type】Monoclonal antibody

【Mechanism of Action】

A human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti- tumor immune response.